Literature DB >> 12749030

Tendon chitosan tubes covalently coupled with synthesized laminin peptides facilitate nerve regeneration in vivo.

Masumi Suzuki1, Soichiro Itoh, Isamu Yamaguchi, Kazuo Takakuda, Hisatoshi Kobayashi, Kenichi Shinomiya, Junzo Tanaka.   

Abstract

We have developed tendon chitosan tubes having the ability to bind peptides covalently, and the effectiveness of laminin peptides coupled to these tubular wall on nerve regeneration was examined in vivo. Bridge graft implantation (15 mm) into the sciatic nerve of SD rats was carried out using chitosan tubes having a triangular cross section containing either covalently bound intact laminin or the laminin peptides CDPGYIGSR or CSRARKQAASIKVAVSAD or being nontreated (N = 20 in each group). As a control, isografting (N = 5) was carried out. Three rats in each experimental group were sacrificed for histology observations after 1, 2, 4, 6, and 8 weeks. The total area of regenerating tissue in the tube and the length of the area where regenerating tissue attached to the inner surface of the tube were measured. In five rats from each experimental and control group, the latency quotient between the implanted and the nontreated site was determined 12 weeks after implantation. Furthermore, the percentage of myelinated axon area was measured at a 10-mm distance from the distal anastomosed site. Histological findings suggest that the immobilized laminin, confirmed by immunostaining as long as 12 weeks postoperatively, as well as laminin oligopeptides may effectively assist nerve tissue extension. According to statistical analysis of the percentage neural tissue found in relation to evoked action potentials, the sequential treatments with YIGSR first followed by IKVAV matched the effectiveness of intact laminin in enhancing nerve regeneration. However, when compared with that after isografting, the enhancement of regenerated axon growth was less sufficient. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749030     DOI: 10.1002/jnr.10589

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

Review 1.  Biomaterial design strategies for the treatment of spinal cord injuries.

Authors:  Karin S Straley; Cheryl Wong Po Foo; Sarah C Heilshorn
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

2.  A chitosan-arginine conjugate as a novel anticoagulation biomaterial.

Authors:  W G Liu; J R Zhang; Z Q Cao; F Y Xu; K D Yao
Journal:  J Mater Sci Mater Med       Date:  2004-11       Impact factor: 3.896

3.  Hyaluronic acid-based scaffold for central neural tissue engineering.

Authors:  Xiumei Wang; Jin He; Ying Wang; Fu-Zhai Cui
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

4.  Enhanced Schwann cell attachment and alignment using one-pot "dual click" GRGDS and YIGSR derivatized nanofibers.

Authors:  Jukuan Zheng; Dimitria Kontoveros; Fei Lin; Geng Hua; Darrell H Reneker; Matthew L Becker; Rebecca K Willits
Journal:  Biomacromolecules       Date:  2014-12-17       Impact factor: 6.988

5.  Adhesion molecule-modified biomaterials for neural tissue engineering.

Authors:  Shreyas S Rao; Jessica O Winter
Journal:  Front Neuroeng       Date:  2009-06-09

Review 6.  Research Progress on Emerging Polysaccharide Materials Applied in Tissue Engineering.

Authors:  Chunyu Su; Yutong Chen; Shujing Tian; Chunxiu Lu; Qizhuang Lv
Journal:  Polymers (Basel)       Date:  2022-08-11       Impact factor: 4.967

7.  Recovery of peripheral nerve with massive loss defect by tissue engineered guiding regenerative gel.

Authors:  Shimon Rochkind; Zvi Nevo
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

8.  Three-layer microfibrous peripheral nerve guide conduit composed of elastin-laminin mimetic artificial protein and poly(L-lactic acid).

Authors:  Sachiro Kakinoki; Midori Nakayama; Toshiyuki Moritan; Tetsuji Yamaoka
Journal:  Front Chem       Date:  2014-07-18       Impact factor: 5.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.